PESCITELLI, LEONARDO
PESCITELLI, LEONARDO
Scienze della Salute (DSS)
A pediatric case of sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy
2016 Lazzeri L.; Tripo L.; Pescitelli L.; Ricceri F.; Prignano F.
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa
2019 Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F.
Clinical characteristics of psoriasis in inflammatory bowel disease patients
2017 Pescitelli L.; Gianotta M.; Ricceri F.; Lazzeri L.; Milla M.; Prignano F.
Clinical experience with infliximab biosimilar in psoriasis
2017 Ricceri F.; Pescitelli L.; Lazzeri L.; Prignano F.
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients
2019 Pescitelli L.; Lazzeri L.; Di Cesare A.; Tripo L.; Ricceri F.; Prignano F.
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?”
2019 Di Cesare A.; Maglie R.; Pescitelli L.; Rosi E.; Prignano F.
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies.
2009 F. Prignano;F. Ricceri;L. Pescitelli;G. Buggiani;M. Troiano;F. Zanieri;S. Rossari;T. Lotti
Curcumin and capsaicin prevent mitochondrial damage and apoptosis in keratinocytes from perilesional vitiligo skin
2009 M. Becatti;C. Fiorillo;N. Taddei;L. Pescitelli;P. Nassi;T. Lotti;F. Prignano
Cutaneous hyperpigmentation induced by apremilast
2018 Di Cesare A.; Pescitelli L.; Ricceri F.; Lazzeri L.; Prignano F.
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect?
2017 Pescitelli, Leonardo; Emmi, Giacomo; Tripo, Lara; Lazzeri, Linda; Urban, Maria Letizia; Silvesri, Elena; Vannucchi, Margherita; Prignano, Francesca
Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis
2013 Ricceri F.; Pescitelli L.; Tripo L.; Prignano F.
Development of MGUS in psoriatic patients: a possible undiagnosed event during anti‐TNF‐α‐treatment
2012 Prignano, F.; Pescitelli, L.; Ricceri, F.; Ermini, A.; Lotti, T.
Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis
2010 Prignano, Francesca; Pescitelli, Leonardo; Ricceri, Federica; Ermini, Angela; Lotti, Torello
Effect of a psoriatic microenvironment in a three-dimensional model of normal human skin
2013 Donetti E.; Cornaghi L.; Sallese G.; Landoni F.; Gramatica F.; Bedoni M.; Pescitelli L.; Prignano F.
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
2019 Esposito M.; Prignano F.; Rongioletti F.; Hansel K.; Bianchi L.; Pescitelli L.; Lazzeri L.; Ricceri F.; Mugheddu C.; Bavetta M.; Zangrilli A.; Bianchi L.; Bini V.; Stingeni L.
Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer
2020 BORGOGNONI, LORENZO; PESCITELLI, LEONARDO; GERLINI, GIANNI; BRANDANI, PAOLA; GELLI, RICCARDO; GIANNOTTI, VANNI; BELLUCCI, FRANCESCO; SESTINI, SERENA
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation
2024 MANZO MARGIOTTA, Flavia; MICHELUCCI, Alessandra; CAPALBO, Eugenio; RICCERI, Federica; ROSI, Elia; ROSSARI, Susanna; MAGNANO, Michela; SAVARESE, Imma; MILANESI, Nicola; SIMONI, Barbara; ROMANELLI, Marco; RUBEGNI, Pietro; DI CESARE, Antonella; PANDURI, Salvatore; PESCITELLI, Leonardo; TROVATO, Emanuele; PRIGNANO, Francesca
Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail
2012 Buggiani, Gionata; D'Erme, Angelo Massimiliano; Krysenka, Alena; Pescitelli, Leonardo; Lotti, Torello; Prignano, Francesca
Epidermal barrier reaction to an in vitro psoriatic microenvironment
2017 Donetti E.; Cornaghi L.; Arnaboldi F.; Ricceri F.; Pescitelli L.; Maiocchi M.; Carriero F.; Baruffaldi Preis F.; Prignano F.
Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis
2015 Pescitelli L.; Dini V.; Gisondi P.; Loconsole F.; Piaserico S.; Piccirillo A.; Stinco G.; Errichetti E.; Talamonti M.; Tripo L.; Volpi W.; Prignano F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A pediatric case of sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy | 2016 | Lazzeri L.; Tripo L.; Pescitelli L.; Ricceri F.; Prignano F. | |
| Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa | 2019 | Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F. | |
| Clinical characteristics of psoriasis in inflammatory bowel disease patients | 2017 | Pescitelli L.; Gianotta M.; Ricceri F.; Lazzeri L.; Milla M.; Prignano F. | |
| Clinical experience with infliximab biosimilar in psoriasis | 2017 | Ricceri F.; Pescitelli L.; Lazzeri L.; Prignano F. | |
| Clinical experience with the etanercept biosimilar SB4 in psoriatic patients | 2019 | Pescitelli L.; Lazzeri L.; Di Cesare A.; Tripo L.; Ricceri F.; Prignano F. | |
| Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” | 2019 | Di Cesare A.; Maglie R.; Pescitelli L.; Rosi E.; Prignano F. | |
| Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. | 2009 | F. Prignano;F. Ricceri;L. Pescitelli;G. Buggiani;M. Troiano;F. Zanieri;S. Rossari;T. Lotti | |
| Curcumin and capsaicin prevent mitochondrial damage and apoptosis in keratinocytes from perilesional vitiligo skin | 2009 | M. Becatti;C. Fiorillo;N. Taddei;L. Pescitelli;P. Nassi;T. Lotti;F. Prignano | |
| Cutaneous hyperpigmentation induced by apremilast | 2018 | Di Cesare A.; Pescitelli L.; Ricceri F.; Lazzeri L.; Prignano F. | |
| Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? | 2017 | Pescitelli, Leonardo; Emmi, Giacomo; Tripo, Lara; Lazzeri, Linda; Urban, Maria Letizia; Silvesri, Elena; Vannucchi, Margherita; Prignano, Francesca | |
| Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis | 2013 | Ricceri F.; Pescitelli L.; Tripo L.; Prignano F. | |
| Development of MGUS in psoriatic patients: a possible undiagnosed event during anti‐TNF‐α‐treatment | 2012 | Prignano, F.; Pescitelli, L.; Ricceri, F.; Ermini, A.; Lotti, T. | |
| Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis | 2010 | Prignano, Francesca; Pescitelli, Leonardo; Ricceri, Federica; Ermini, Angela; Lotti, Torello | |
| Effect of a psoriatic microenvironment in a three-dimensional model of normal human skin | 2013 | Donetti E.; Cornaghi L.; Sallese G.; Landoni F.; Gramatica F.; Bedoni M.; Pescitelli L.; Prignano F. | |
| Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice | 2019 | Esposito M.; Prignano F.; Rongioletti F.; Hansel K.; Bianchi L.; Pescitelli L.; Lazzeri L.; Ricceri F.; Mugheddu C.; Bavetta M.; Zangrilli A.; Bianchi L.; Bini V.; Stingeni L. | |
| Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer | 2020 | BORGOGNONI, LORENZO; PESCITELLI, LEONARDO; GERLINI, GIANNI; BRANDANI, PAOLA; GELLI, RICCARDO; GIANNOTTI, VANNI; BELLUCCI, FRANCESCO; SESTINI, SERENA | |
| Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation | 2024 | MANZO MARGIOTTA, Flavia; MICHELUCCI, Alessandra; CAPALBO, Eugenio; RICCERI, Federica; ROSI, Elia; ROSSARI, Susanna; MAGNANO, Michela; SAVARESE, Imma; MILANESI, Nicola; SIMONI, Barbara; ROMANELLI, Marco; RUBEGNI, Pietro; DI CESARE, Antonella; PANDURI, Salvatore; PESCITELLI, Leonardo; TROVATO, Emanuele; PRIGNANO, Francesca | |
| Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail | 2012 | Buggiani, Gionata; D'Erme, Angelo Massimiliano; Krysenka, Alena; Pescitelli, Leonardo; Lotti, Torello; Prignano, Francesca | |
| Epidermal barrier reaction to an in vitro psoriatic microenvironment | 2017 | Donetti E.; Cornaghi L.; Arnaboldi F.; Ricceri F.; Pescitelli L.; Maiocchi M.; Carriero F.; Baruffaldi Preis F.; Prignano F. | |
| Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis | 2015 | Pescitelli L.; Dini V.; Gisondi P.; Loconsole F.; Piaserico S.; Piccirillo A.; Stinco G.; Errichetti E.; Talamonti M.; Tripo L.; Volpi W.; Prignano F. |